Remote Ischemic Conditioning for Treatment of Chronic Wounds

Status Not yet recruiting

Clinical Trial Summary

The goals of this series of studies is to test the effect of RIC on chronic leg ulcers (Diabetic ulcers and venous ulcers) - and to improve the understanding of its biological mechanism. This is a prospective, double-blind, randomized, shame procedure-controlled study.

Clinical Trial Description

After getting patients informed consent. Initial evaluation that includes: Venous and Arterial vascular evaluation, Medical past History including medications and surgeries Documentation of the chronic wounds by description and photography with scale.

Base line blood test for CBC, HbA1C, Electrolytes, Urea, Cr, Liver enzymes. IL 1 IL 6 VEGF NO CD34 Adenosine All patients will received the standard wound care in use by the staff of the chronic wound clinic. Care givers will be blinded as to the study allocation of each patient. Patients will be divided randomly into two equal groups. Pressure cuffs will be applied to both arms of all subjects. The cuffs will be inflated and deflated intermittently for three cycles of 5 minutes each. In the study group, the cuffs will be inflated to 50 mmHg above systolic blood pressure while the performing investigator examines the radial pulse to ensure complete blood flow obstruction. In the control group, inflation will be up to 10 mmHg only. The patients will be followed for 10 weeks.

During this period, they will be examined every 2 weeks (5 follow-up visits); and in each of these visits the above procedure will be repeated including blood collection before intervention and 24-48h after intervention.

In each visit a "blinded" physician will photograph with scale the wound and grade the granulation tissue covering the wound on a scale from 0 to 5.

The primary end point of the study is the number of healed wounds and wound area change among the two groups. Secondary outcomes will be the degree of granulation tissue and levels of IL 1 IL 6 VEGF NO CD34 Adenosine ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02873728
Study type	Interventional
Source	Soroka University Medical Center
Contact	Eldad Silberstein, MD
Phone	+972-8-6400880
Email	eldads@bgu.ac.il
Status	Not yet recruiting
Phase	N/A
Start date	November 2016
Completion date	February 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03644849` - Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing	N/A
Recruiting	`NCT02842502` - Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Case of Chronic Leg Ulcers	N/A
Active, not recruiting	`NCT01903044` - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating	Phase 1/Phase 2
Terminated	`NCT01966380` - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia	Phase 2
Terminated	`NCT02509533` - Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method	N/A
Completed	`NCT00371371` - Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)	Phase 1/Phase 2
Active, not recruiting	`NCT00270972` - The Evaluation of OrCel for the Treatment of Venous Ulcers	N/A
Terminated	`NCT01657318` - Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Completed	`NCT02392390` - Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds	N/A
Not yet recruiting	`NCT06007703` - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Recruiting	`NCT02987101` - Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction	N/A
Active, not recruiting	`NCT02973893` - Study of VF001-DP in Patients With Chronic Venous Leg Ulcers	Phase 2
Completed	`NCT01551667` - Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds	N/A
Completed	`NCT01497210` - EASH Dressing on Chronic Venous Leg Ulcers	Phase 2
Completed	`NCT00235209` - A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers	Phase 4
Not yet recruiting	`NCT06153589` - Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care	N/A
Completed	`NCT01591434` - Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers	Phase 3
Completed	`NCT00838500` - THERMES ET VEINES: Spa for Prevention of Leg Ulcers	Phase 3
Completed	`NCT00243620` - A Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings	N/A
Recruiting	`NCT05303805` - Topical Sevoflurane for Treatment of Chronic Leg Ulcers	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.